R Ohno

8.3k total citations · 1 hit paper
104 papers, 5.7k citations indexed

About

R Ohno is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, R Ohno has authored 104 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 41 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in R Ohno's work include Acute Myeloid Leukemia Research (37 papers), Acute Lymphoblastic Leukemia research (20 papers) and Retinoids in leukemia and cellular processes (18 papers). R Ohno is often cited by papers focused on Acute Myeloid Leukemia Research (37 papers), Acute Lymphoblastic Leukemia research (20 papers) and Retinoids in leukemia and cellular processes (18 papers). R Ohno collaborates with scholars based in Japan, United States and Italy. R Ohno's co-authors include T Naoe, Hidehiko Saito, Kazunori Ohnishi, David Head, Roel Willemze, Richard A. Larson, John M. Bennett, Bruce D. Cheson, Wolfgang Hiddemann and Elihu H. Estey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Heart Journal.

In The Last Decade

R Ohno

99 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

2003 1.9k citations R Ohno et al. profile →

Peers

Countries citing papers authored by R Ohno

Since Specialization

Citations

This map shows the geographic impact of R Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Ohno more than expected).

Fields of papers citing papers by R Ohno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Ohno. The network helps show where R Ohno may publish in the future.

Co-authorship network of co-authors of R Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of R Ohno. A scholar is included among the top collaborators of R Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Ohno. R Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Staple oligomers induce a stable RNA G-quadruplex structure for protein translation inhibition in therapeutics 2025 ·Nature Biomedical Engineering ·Yousuke Katsuda, (unknown), (unknown), R Ohno, (unknown), Yasunobu Hasegawa, Kozo Utsumi, Yuki Sakamoto, Shinichiro Nakamura, Taishi Nakamura, (unknown), Yusuke Kitamura, Yukiko Kamiya, Hiroyuki Asanuma, Toshihiro Ihara, Masaki Hagihara, Shin‐ichi Sato	0
2	Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus 2023 ·Journal of Endocrinological Investigation ·Yuta Suzuki, Hidehiro Kaneko, Akira Okada, R Ohno, Isao Yokota, Katsuhito Fujiu, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Koichi Node, Hideo Yasunaga, Issei Komuro	11
3	Development of Polymer Composite Membranes with Hydrophilic TiO₂ Nanoparticles and Perfluorosulfonic Acid-Based Electrolyte for Polymer Electrolyte Fuel Cells Operating over a Wide Temperature Range 2023 ·ACS Applied Energy Materials ·R Ohno, (unknown), Tetsuro Tano, Katsuyoshi Kakinuma	10
4	Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia 2010 ·Leukemia ·Shuichi Mizuta, Keitaro Matsuo, Fumiharu Yagasaki, Toshiaki Yujiri, Yoshihiro Hatta, Yui Kimura, Yasunori Ueda, Heiwa Kanamori, Noriko Usui, Hideki Akiyama, Yasushi Miyazaki, Shigeki Ohtake, Yoshiko Atsuta, Hisashi Sakamaki, K Kawa, Y Morishima, Kazunori Ohnishi, T Naoe, R Ohno	74
5	Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy 2008 ·Haematologica ·Masamitsu Yanada, (unknown), Isamu Sugiura, Hideki Akiyama, Noriko Usui, (unknown), Kazuhiro Nishii, Yasunori Ueda, (unknown), (unknown), A Maruta, Hiroto Narimatsu, Yasushi Miyazaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, T Naoe, R Ohno, (unknown)	45
6	Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial 2006 ·Journal of Thrombosis and Haemostasis ·Hiroaki Saito, Ikuro Maruyama, S Shimazaki, Yasuhiro Yamamoto, Naoki Aikawa, R Ohno, Akio Hirayama, T Matsuda, Hidesaku Asakura, Megan O. Nakashima, N Aoki	446
7	Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome 2005 ·Leukemia ·(unknown), Hitoshi Kiyoi, K. Ozeki, T. Kinoshita, Nobuhiko Emi, R Ohno, T Naoe	32
8	Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring 2002 ·Leukemia ·Kazunori Ohnishi, Hitoshi Yoshida, Kohichiro Shigeno, Shota Nakamura, Shinya Fujisawa, Kensuke Naito, Kaori Shinjo, (unknown), Hirotaka Matsui, Naruhiko Sahara, Akihiro Takeshita, Hiroshi Satoh, (unknown), R Ohno	74
9	Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers 2002 ·Leukemia ·Hirotaka Matsui, Akihiro Takeshita, Kensuke Naito, Kaori Shinjo, Kohichiro Shigeno, Masato Maekawa, Yoshinori Yamakawa, (unknown), Miki Kobayashi, Kazunori Ohnishi, R Ohno	81
10	Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Adult Leukemia Study Group AML-92 and AML-95 databases. 2000 ·PubMed ·Akitaka Suzuki, Kazuma Ohyashiki, Yukihiko Kimura, Hiroya Yamada, Fumiaki Sano, (unknown), (unknown), R Ohno	2
11	Multicenter cooperative study group in hematology in Japan: the 10-year history and role of the Japan Adult Leukemia Study Group in Japan. 1998 ·PubMed ·R Ohno	1
12	Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia 1998 ·Leukemia ·Kazunori Ohnishi, (unknown), K Naito, (unknown), S Yokomaku, Norio Hirabayashi, R Ohno	23
13	Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product 1998 ·Leukemia ·Hitoshi Kiyoi, Masayuki Towatari, Shohei Yokota, Motohiro Hamaguchi, R Ohno, Hidehiko Saito, T Naoe	362
14	Treatment of adult T-cell leukaemia–lymphoma with irinotecan hydrochloride (CPT-11) 1994 ·British Journal of Cancer ·(unknown), Hiroyuki Tsuda, Kiyoshi Takatsuki, R Ohno, T Masaoka, Kosuke Okada, S Shirakawa, Yasukata Ohashi, Ota K	63
15	G-CSF in the Treatment of Acute Myeloid Leukemia: Is it safe? 1993 ·Leukemia & lymphoma ·R Ohno	8
16	Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG). 1992 ·PubMed ·R Ohno, Toshiyuki Kobayashi, Y Morishima, A Hiraoka, Kenichiro Imai, Norichika Asoh, Kazuo Tsubaki, Masao Tomonaga, Isao Takahashi, (unknown)	12
17	Antibody dependent cell mediated cytotoxicity on human cervical carcinoma cell line, ME-180, with human monoclonal antibody 1992 ·Cancer Letters ·Kazuoki Osumi, (unknown), H Yuasa, Hirokazu Fujimoto, H. Hagiwara, (unknown), R Ohno	5
18	STUDY ON THE EVALUATING METHOD OF SLIPPERINESS OF BATHROOM FLOORS AND BATHTUB BOTTOMS FROM A VIEWPOINT OF SAFETY : Part 2 : Presentation of the evaluating indexes and the evaluating method of slipperiness of bathroom floors and bathtub bottoms 1988 ·Journal of Structural and Construction Engineering (Transactions of AIJ) ·(unknown), (unknown), R Ohno, (unknown), (unknown), (unknown)	1
19	STUDY ON HARDNESS OF BUILDING FLOORS AND ITS METHOD OF EVALUATION FROM A VIEWPOINT OF COMFORTABLENESS : Part 1 The scaling of human senses on Hardness of building floors 1985 ·Journal of Structural and Construction Engineering (Transactions of AIJ) ·(unknown), (unknown), R Ohno	3
20	Extraction and identification of leukemia associated antigen. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Yasuhiro Kato, R Ohno, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact